We have selected a suitable target, designed RPA primers and crRNA to successfully establish a reliable RPA-CRISPR/Cas12a assay for detection of MP, and then preliminary validated the feasibility of the proposed method in this study. The gene discussed is RPA1; the disease is hyperplastic polyp.